Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murat Cokol

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|May 21, 2019
Characterizing ABC-Transporter Substrate-Likeness Using a Clean-Slate Genetic BackgroundArtem Sokolov, Stephanie Ashenden, Nil Sahin, et al.
Oncotargets and Therapy|November 24, 2016
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinomaVictor Jeannot, Benoit Busser, Laetitia Vanwonterghem, et al.
Current Biology : CB|November 7, 2017
A Parallel Adder Coordinates Mycobacterial Cell-Cycle Progression and Cell-Size Homeostasis in the Context of Asymmetric Growth and OrganizationMichelle M Logsdon, Po-Yi Ho, Kadamba Papavinasasundaram, et al.
Scientific Reports|June 5, 2021
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell modelsNadine Daou, Andreu Viader, Murat Cokol, et al.
Journal of Medicinal Chemistry|April 7, 2017
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular StructureDaniel J Mason, Ian Stott, Stephanie Ashenden, et al.
Drug Discovery Today|September 12, 2015
Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectivesKrishna C Bulusu, Rajarshi Guha, Daniel J Mason, et al.
Journal of Chemical Information and Modeling|July 16, 2014
Target-independent prediction of drug synergies using only drug lipophilicityKaan Yilancioglu, Zohar B Weinstein, Cem Meydan, et al.
Nature Communications|August 29, 2018
Modeling the impact of drug interactions on therapeutic selectivityZohar B Weinstein, Nurdan Kuru, Szilvia Kiriakov, et al.
Molecular Biology and Evolution|June 26, 2014
Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolutionTugce Oz, Aysegul Guvenek, Sadik Yildiz, et al.
Nature Communications|September 10, 2020
Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelopeEdward Geisinger, Nadav J Mortman, Yunfei Dai, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|May 21, 2019
Characterizing ABC-Transporter Substrate-Likeness Using a Clean-Slate Genetic BackgroundArtem Sokolov, Stephanie Ashenden, Nil Sahin, et al.
Oncotargets and Therapy|November 24, 2016
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinomaVictor Jeannot, Benoit Busser, Laetitia Vanwonterghem, et al.
Current Biology : CB|November 7, 2017
A Parallel Adder Coordinates Mycobacterial Cell-Cycle Progression and Cell-Size Homeostasis in the Context of Asymmetric Growth and OrganizationMichelle M Logsdon, Po-Yi Ho, Kadamba Papavinasasundaram, et al.
Scientific Reports|June 5, 2021
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell modelsNadine Daou, Andreu Viader, Murat Cokol, et al.
Journal of Medicinal Chemistry|April 7, 2017
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular StructureDaniel J Mason, Ian Stott, Stephanie Ashenden, et al.
Drug Discovery Today|September 12, 2015
Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectivesKrishna C Bulusu, Rajarshi Guha, Daniel J Mason, et al.
Journal of Chemical Information and Modeling|July 16, 2014
Target-independent prediction of drug synergies using only drug lipophilicityKaan Yilancioglu, Zohar B Weinstein, Cem Meydan, et al.
Nature Communications|August 29, 2018
Modeling the impact of drug interactions on therapeutic selectivityZohar B Weinstein, Nurdan Kuru, Szilvia Kiriakov, et al.
Molecular Biology and Evolution|June 26, 2014
Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolutionTugce Oz, Aysegul Guvenek, Sadik Yildiz, et al.
Nature Communications|September 10, 2020
Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelopeEdward Geisinger, Nadav J Mortman, Yunfei Dai, et al.
Pageof 4